Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
  2. 4 Grant or award Chief Scientific & Dev. Ofc. acquired 75,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award SVP of Corp. Dev. acquired 20,000 shares (grant or award)
  6. 4 Grant or award SVP of Finance acquired 40,000 shares (grant or award)
  7. 4 Shares withheld for taxes SVP of Finance gave up 3,950 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Business Officer gave up 1,282 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP of Corp. Dev. gave up 4,031 shares (to pay taxes)
  10. 4 Grant or award Director acquired 14,964 shares (grant or award)
  11. 4 Grant or award Director acquired 22,090 shares (grant or award)
  12. 4 Grant or award Director acquired 24,762 shares (grant or award)
  13. 4 Grant or award Director acquired 19,418 shares (grant or award)
  14. 4 Grant or award Chief Business Officer acquired 49,692 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 35,000 shares (grant or award)
  18. 4 Grant or award Director acquired 35,000 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 400,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 21 · 403 filings